Ventyx Biosciences
VTYX
VTYX was delisted on the 3rd of March, 2026.
63 hedge funds and large institutions have $408M invested in Ventyx Biosciences in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 4 closing their positions.
225% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 4
100% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 13
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
15% more funds holding
Funds holding: 55 → 63 (+8)
2.59% more ownership
Funds ownership: 65.51% → 68.1% (+2.6%)
9% less capital invested
Capital invested by funds: $448M → $408M (-$40.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.3M |
| 2 |
BlackRock
New York
|
+$8.46M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.43M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.3M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$2.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.05M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$3.42M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$3.01M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$2.74M |
| 5 |
Millennium Management
New York
|
-$1.19M |
VTYX Hedge Fund Activity: Q2 2022 in Review
63 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q2 2022, worth a combined $408M — down 9.1% from $448M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new VTYX positions and 4 closed out — a net gain of 9 holders — while 26 added to existing stakes and 13 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $11.3M. The largest seller was Wellington Management Group, cutting an estimated $9.05M.
- 63 institutional investors held Ventyx Biosciences (VTYX) as of Q2 2022, up from 55 in Q1 2022.
- Funds reported $408M of Ventyx Biosciences stock for Q2 2022, down 9.1% quarter-over-quarter.
- 13 funds opened new Ventyx Biosciences positions in Q2 2022 and 4 closed out, a net change of +9 holders.
- The largest Ventyx Biosciences buyer in Q2 2022 was Fidelity Investments, an estimated $11.3M added.
- The largest Ventyx Biosciences seller in Q2 2022 was Wellington Management Group, an estimated $9.05M sold.
Based on aggregated 13F filings for Q2 2022.